Global Candidiasis Therapeutics Market Survey and Trend Research 2018

June 2018 | 83 pages | ID: G81AB800A1FEN
99Strategy

Abstracts

Summary

This report describes the development of the industry by upstream & downstream, industry overall and development, key companies, as well as type segment & market application and so on, and makes a scientific prediction for the development industry prospects on the basis of analysis, finally, analyzes opportunities for investment in the industry at the end of the report.

Industry Chain

• Raw Materials
• Cost
• Technology
• Consumer Preference

Industry Overall:

• History
• Development & Trend
• Market Competition
• Trade Overview
• Policy

Region (North America, Europe, Asia-Pacific, South America, Middle East, Africa):

• Regional Market
• Production Development
• Sales
• Regional Trade
• Regional Forecast

Company (Novartis AG, Amgen, F. Hoffmann-La Roche Ltd., Bayer-Algeta, Ablynx, Ablynx, Genta Incorporated, Galapagos NV, Catena Pharmaceuticals Inc., Digna Biotech S.L., Medivir AB, Amura Holdings etc.):

• Company Profile
• Product & Service
• Business Operation Data
• Market Share

Investment Analysis:

• Market Features
• Investment Opportunity
• Investment Calculation

Contents

PART 1 INDUSTRY OVERVIEW

1.1 Candidiasis Therapeutics Industry
  1.1.1 Definition
  1.1.2 Industry Trend
1.2 Industry Chain
  1.2.1 Upstream
  1.2.2 Technology
  1.2.3 Cost Structure
  1.2.4 Consumer Preference
  1.2.2 Downstream

PART 2 INDUSTRY OVERALL

2.1 Industry History
2.2 Development Prospect
2.3 Competition Structure
2.4 Relevant Policy
2.5 Trade Overview

PART 3 CANDIDIASIS THERAPEUTICS MARKET BY PRODUCT

3.1 Products List of Major Companies
3.2 Market Size
3.3 Market Forecast

4 KEY COMPANIES LIST

4.1 Novartis AG (Company Overview, Sales Data etc.)
  4.1.1 Company Overview
  4.1.2 Products and Services
  4.1.3 Business Analysis
4.2 Amgen (Company Overview, Sales Data etc.)
  4.2.1 Company Overview
  4.2.2 Products and Services
  4.2.3 Business Analysis
4.3 F. Hoffmann-La Roche Ltd. (Company Overview, Sales Data etc.)
  4.3.1 Company Overview
  4.3.2 Products and Services
  4.3.3 Business Analysis
4.4 Bayer-Algeta (Company Overview, Sales Data etc.)
  4.4.1 Company Overview
  4.4.2 Products and Services
  4.4.3 Business Analysis
4.5 Ablynx (Company Overview, Sales Data etc.)
  4.5.1 Company Overview
  4.5.2 Products and Services
  4.5.3 Business Analysis
4.6 Ablynx (Company Overview, Sales Data etc.)
  4.6.1 Company Overview
  4.6.2 Products and Services
  4.6.3 Business Analysis
4.7 Genta Incorporated (Company Overview, Sales Data etc.)
  4.7.1 Company Overview
  4.7.2 Products and Services
  4.7.3 Business Analysis
4.8 Galapagos NV (Company Overview, Sales Data etc.)
  4.8.1 Company Overview
  4.8.2 Products and Services
  4.8.3 Business Analysis
4.9 Catena Pharmaceuticals Inc. (Company Overview, Sales Data etc.)
  4.9.1 Company Overview
  4.9.2 Products and Services
  4.9.3 Business Analysis
4.10 Digna Biotech S.L. (Company Overview, Sales Data etc.)
  4.10.1 Company Overview
  4.10.2 Products and Services
  4.10.3 Business Analysis
4.11 Medivir AB (Company Overview, Sales Data etc.)
4.12 Amura Holdings (Company Overview, Sales Data etc.)

PART 5 MARKET COMPETITION

5.1 Companies Competition
5.2 Industry Competition Structure Analysis
  5.2.1 Rivalry
  5.2.2 Threat of New Entrants
  5.2.3 Substitutes
  5.2.4 Bargaining Power of Suppliers
  5.2.5 Bargaining Power of Buyers

PART 6 MARKET DEMAND BY SEGMENT

6.1 Demand Situation
  6.1.1 Industry Application Status
  6.1.2 Industry SWOT Analysis
    6.1.2.1 Strengths
    6.1.2.2 Weaknesses
    6.1.2.3 Opportunities
    6.1.2.4 Threats
6.2 Major Customer Survey
6.3 Demand Forecast

PART 7 REGION OPERATION

7.1 Regional Market
7.2 Production and Sales by Region
  7.2.1 Production
  7.2.2 Sales
  7.2.3 Trade
7.3 Regional Forecast

PART 8 MARKET INVESTMENT

8.1 Market Features
  8.1.1 Product Features
  8.1.2 Price Features
  8.1.3 Channel Features
  8.1.4 Purchasing Features
8.2 Investment Opportunity
  8.2.1 Regional Investment Opportunity
  8.2.2 Industry Investment Opportunity
8.3 Investment Calculation
  8.3.1 Cost Calculation
  8.3.2 Revenue Calculation
  8.3.3 Economic Performance Evaluation

PART 9 CONCLUSION

List Of Tables

LIST OF TABLES

Table Global Candidiasis Therapeutics Market 2012-2017, by Type, in USD Million
Table Global Candidiasis Therapeutics Market 2012-2017, by Type, in Volume
Table Global Candidiasis Therapeutics Market Forecast 2018-2023, by Type, in USD Million
Table Global Candidiasis Therapeutics Market Forecast 2018-2023, by Type, in Volume
Table Novartis AG Overview List
Table Candidiasis Therapeutics Business Operation of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amgen Overview List
Table Candidiasis Therapeutics Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Overview List
Table Candidiasis Therapeutics Business Operation of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Bayer-Algeta Overview List
Table Candidiasis Therapeutics Business Operation of Bayer-Algeta (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ablynx Overview List
Table Candidiasis Therapeutics Business Operation of Ablynx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Ablynx Overview List
Table Candidiasis Therapeutics Business Operation of Ablynx (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genta Incorporated Overview List
Table Candidiasis Therapeutics Business Operation of Genta Incorporated (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Galapagos NV Overview List
Table Candidiasis Therapeutics Business Operation of Galapagos NV (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Catena Pharmaceuticals Inc. Overview List
Table Candidiasis Therapeutics Business Operation of Catena Pharmaceuticals Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Digna Biotech S.L. Overview List
Table Candidiasis Therapeutics Business Operation of Digna Biotech S.L. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Medivir AB Overview List
Table Candidiasis Therapeutics Business Operation of Medivir AB (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Amura Holdings Overview List
Table Candidiasis Therapeutics Business Operation of Amura Holdings (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Global Candidiasis Therapeutics Sales Revenue 2012-2017, by Companies, in USD Million
Table Global Candidiasis Therapeutics Sales Revenue Share, by Companies, in USD Million
Table Global Candidiasis Therapeutics Sales Volume 2012-2017, by Companies, in Volume
Table Global Candidiasis Therapeutics Sales Revenue Share, by Companies in 2017, in Volume
Table Candidiasis Therapeutics Demand 2012-2017, by Application, in USD Million
Table Candidiasis Therapeutics Demand 2012-2017, by Application, in Volume
Table Candidiasis Therapeutics Demand Forecast 2018-2023, by Application, in USD Million
Table Candidiasis Therapeutics Demand Forecast 2018-2023, by Application, in Volume
Table Global Candidiasis Therapeutics Market 2012-2017, by Region, in USD Million
Table Global Candidiasis Therapeutics Market 2012-2017, by Region, in Volume
Table Candidiasis Therapeutics Market Forecast 2018-2023, by Region, in USD Million
Table Candidiasis Therapeutics Market Forecast 2018-2023, by Region, in Volume

List Of Figures

LIST OF FIGURES

Figure Candidiasis Therapeutics Industry Chain Structure
Figure Global Candidiasis Therapeutics Market Growth 2012-2017, by Type, in USD Million
Figure Global Candidiasis Therapeutics Market Growth 2012-2017, by Type, in Volume
Figure Global Candidiasis Therapeutics Sales Revenue Share, by Companies in 2017, in USD Million
Figure Global Candidiasis Therapeutics Sales Volume Share 2012-2017, by Companies, in Volume
Figure Production Development by Region
Figure Sales List by Region